Amy Jo Sterling

Array ( [id] => 1418067 [patent_doc_number] => 06506569 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Antibodies to human tumor necrosis factor receptor TR10' [patent_app_type] => B1 [patent_app_number] => 09/580212 [patent_app_country] => US [patent_app_date] => 2000-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 89421 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 113 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506569.pdf [firstpage_image] =>[orig_patent_app_number] => 09580212 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7615227 [patent_doc_number] => 06897297 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-24 [patent_title] => 'Hydrophobically-modified protein compositions and methods' [patent_app_type] => utility [patent_app_number] => 09/579680 [patent_app_country] => US [patent_app_date] => 2000-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 27 [patent_no_of_words] => 33688 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/897/06897297.pdf [firstpage_image] =>[orig_patent_app_number] => 09579680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1513829 [patent_doc_number] => 06419929 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-16 [patent_title] => 'Recombinant RANK-L polypeptide' [patent_app_type] => B1 [patent_app_number] => 09/577780 [patent_app_country] => US [patent_app_date] => 2000-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 27187 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/419/06419929.pdf [firstpage_image] =>[orig_patent_app_number] => 09577780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1448902 [patent_doc_number] => 06455040 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-24 [patent_title] => 'Tumor necrosis factor receptor 5' [patent_app_type] => B1 [patent_app_number] => 09/573986 [patent_app_country] => US [patent_app_date] => 2000-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 24 [patent_no_of_words] => 89729 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/455/06455040.pdf [firstpage_image] =>[orig_patent_app_number] => 09573986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 644727 [patent_doc_number] => 07118746 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-10-10 [patent_title] => 'Conditioned cell culture medium compositions and methods of use' [patent_app_type] => utility [patent_app_number] => 09/979813 [patent_app_country] => US [patent_app_date] => 2000-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 21759 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/118/07118746.pdf [firstpage_image] =>[orig_patent_app_number] => 09979813 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1600861 [patent_doc_number] => 06475987 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-05 [patent_title] => 'Tall-1 receptor homologues' [patent_app_type] => B1 [patent_app_number] => 09/565423 [patent_app_country] => US [patent_app_date] => 2000-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 32848 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/475/06475987.pdf [firstpage_image] =>[orig_patent_app_number] => 09565423 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 732168 [patent_doc_number] => 07037665 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-05-02 [patent_title] => 'Compositions comprising SNORF36 receptor compounds' [patent_app_type] => utility [patent_app_number] => 10/018192 [patent_app_country] => US [patent_app_date] => 2000-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 42 [patent_no_of_words] => 34380 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/037/07037665.pdf [firstpage_image] =>[orig_patent_app_number] => 10018192 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 999677 [patent_doc_number] => 06911528 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-06-28 [patent_title] => 'Hedgehog-derived polypeptides' [patent_app_type] => utility [patent_app_number] => 09/562914 [patent_app_country] => US [patent_app_date] => 2000-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 132 [patent_no_of_words] => 51155 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/911/06911528.pdf [firstpage_image] =>[orig_patent_app_number] => 09562914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1208342 [patent_doc_number] => 06713061 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-03-30 [patent_title] => 'Death domain containing receptors' [patent_app_type] => B1 [patent_app_number] => 09/557908 [patent_app_country] => US [patent_app_date] => 2000-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 89015 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/713/06713061.pdf [firstpage_image] =>[orig_patent_app_number] => 09557908 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1012558 [patent_doc_number] => 06897029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-05-24 [patent_title] => 'MCK-10 a novel receptor tyrosine kinase' [patent_app_type] => utility [patent_app_number] => 09/551188 [patent_app_country] => US [patent_app_date] => 2000-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 45 [patent_no_of_words] => 13134 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/897/06897029.pdf [firstpage_image] =>[orig_patent_app_number] => 09551188 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1579331 [patent_doc_number] => 06448382 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-10 [patent_title] => 'Analysis and separation of platelet-derived growth factor proteins' [patent_app_type] => B1 [patent_app_number] => 09/549290 [patent_app_country] => US [patent_app_date] => 2000-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 9790 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/448/06448382.pdf [firstpage_image] =>[orig_patent_app_number] => 09549290 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1395582 [patent_doc_number] => 06534061 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-18 [patent_title] => 'Tumor necrosis factor receptor homologs and nucleic acids encoding the same' [patent_app_type] => B1 [patent_app_number] => 09/548130 [patent_app_country] => US [patent_app_date] => 2000-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 25 [patent_no_of_words] => 31025 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/534/06534061.pdf [firstpage_image] =>[orig_patent_app_number] => 09548130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1098431 [patent_doc_number] => 06818220 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-11-16 [patent_title] => 'Vascular endothelial growth factor C (VEGF-C) protein and gene mutants thereof, and uses thereof' [patent_app_type] => B1 [patent_app_number] => 09/534376 [patent_app_country] => US [patent_app_date] => 2000-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 20 [patent_no_of_words] => 48299 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 74 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/818/06818220.pdf [firstpage_image] =>[orig_patent_app_number] => 09534376 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 946678 [patent_doc_number] => 06965012 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-11-15 [patent_title] => 'Flint polypeptide analogs' [patent_app_type] => utility [patent_app_number] => 09/936024 [patent_app_country] => US [patent_app_date] => 2000-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22136 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/965/06965012.pdf [firstpage_image] =>[orig_patent_app_number] => 09936024 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1584014 [patent_doc_number] => 06358508 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-19 [patent_title] => 'Antibodies to human tumor necrosis factor receptor TR9' [patent_app_type] => B1 [patent_app_number] => 09/527236 [patent_app_country] => US [patent_app_date] => 2000-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 92622 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/358/06358508.pdf [firstpage_image] =>[orig_patent_app_number] => 09527236 [rel_patent_id] =>[rel_patent_doc_number] =>)